logo
transparent transparent

Szczegóły wiadomości

Do domu > Nowości >

Informacje o firmie Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection

Wydarzenia
Skontaktuj się z nami
Ms. Haileeping
86-0554-2796186
Skontaktuj się teraz

Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection

2026-02-05

Major Announcement: Sunhere Pharmaceutical Excipients Successfully Passes U.S. FDA On-Site Inspection, 

Marking Another Milestone in Its Global Layout!


The company has successfully completed the U.S. FDA on-site inspection and received the official Establishment Inspection Report (EIR) confirmation!


najnowsze wiadomości o firmie Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection  0


This inspection covered the entire system, including quality management, production, facilities and equipment, quality control, and materials management. It marks the first time the company has obtained this authoritative FDA qualification. This not only signifies that Sunhere Pharmaceutical Excipients' GMP management system fully aligns with top international standards, but also means its products hold the core passport to enter the global market.


najnowsze wiadomości o firmie Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection  1


As a leading domestic manufacturer of oral solid dosage form pharmaceutical excipients, Sunhere Pharmaceutical Excipients has continuously consolidated its global competitive barriers. Moving forward, the company will empower global customers with higher standards, advance the domestic substitution of pharmaceutical excipients, and accelerate its expansion into the global pharmaceutical ecosystem!

transparent
Szczegóły wiadomości
Do domu > Nowości >

Informacje o firmie-Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection

Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection

2026-02-05

Major Announcement: Sunhere Pharmaceutical Excipients Successfully Passes U.S. FDA On-Site Inspection, 

Marking Another Milestone in Its Global Layout!


The company has successfully completed the U.S. FDA on-site inspection and received the official Establishment Inspection Report (EIR) confirmation!


najnowsze wiadomości o firmie Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection  0


This inspection covered the entire system, including quality management, production, facilities and equipment, quality control, and materials management. It marks the first time the company has obtained this authoritative FDA qualification. This not only signifies that Sunhere Pharmaceutical Excipients' GMP management system fully aligns with top international standards, but also means its products hold the core passport to enter the global market.


najnowsze wiadomości o firmie Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection  1


As a leading domestic manufacturer of oral solid dosage form pharmaceutical excipients, Sunhere Pharmaceutical Excipients has continuously consolidated its global competitive barriers. Moving forward, the company will empower global customers with higher standards, advance the domestic substitution of pharmaceutical excipients, and accelerate its expansion into the global pharmaceutical ecosystem!